Recro Pharma, Inc. 4
4 · Recro Pharma, Inc. · Filed Jun 2, 2016
Insider Transaction Report
Form 4
Graff Fred
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2016-05-31$8.46/sh+8,000$67,707→ 8,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.43 to $8.48, inclusive. The reporting person undertakes to provide to Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.